USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/24266
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPalarie, Natalia-
dc.contributor.authorPalii, Natalia-
dc.contributor.authorPalarie, Victor-
dc.date.accessioned2023-05-10T10:10:02Z-
dc.date.available2023-05-10T10:10:02Z-
dc.date.issued2023-
dc.identifier.citationPALARIE, Natalia, PALII, Natalia, PALARIE, Victor. Platelet rich growth factor in the treatment of complex corneal disorders. In: Cells and Tissues Transplantation. Actualities and Perspectives: the materials of the national scientific conf. with internat. participation, Chișinău: CEP Medicina. 2023, p. 36. ISBN 978-9975-82-313-5.en_US
dc.identifier.isbn978-9975-82-313-5-
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/24266-
dc.description.abstractBackground. Platelet rich growth factor (PRGF) is an autologous blood product rich in proteins and growth factors which can be rapidly obtained from patient blood. Clinically, it is an affordable treatment with potentially broad spectrum of applications in ophthalmology especially in the treatment of complex or refractory corneal wounds. The aim of this study was to evaluate the efficiency of autologous platelet-rich factor in the treatment of complex corneal disorders. The study was performed at the Ophthalmology Department of International Clinic, Orhei, Moldova in January - December 2022. Materials and Methods. There were 28 patients with corneal surface disorders, among which 7 patients with chemical burns, 4 patients with corneal ulcers, 5 patients with corneal dystrophies, 8 with advanced pterygium and 4 with neurotrophic keratopathy. Visual acuity varied from hand motion to 0.7. Solid PRGF was either just placed on the corneal surface or sutured with 2 nodes of 10-00 nylon suture at conjunctiva. If necessary, the procedure was repeated. All patients had corneal OCT scan before and after the treatment. Results. Improved visual acuity and less subjective symptoms were observed in all patients. Complete healing of cornea was observed in all patients with chemical burns and corneal dystrophies. As well considerable improvement experienced 3 of 4 patients with corneal ulcers (reduced size and depth of the ulceration, improved visual acuity, smaller conjunctival injection). Also an improvement was seen in 2 of 4 patients with neurotrophic keratopathy. All patients after pterygium surgery had clear cornea and no recurrences over 6-month period after treatment None of the patients reported general or local side effects of the treatment. Conclusions: PRGF is a reliable and effective therapeutic tool to promote wound healing in complex corneal disorders.en_US
dc.language.isoenen_US
dc.publisherCEP Medicinaen_US
dc.relation.ispartof„Cells and tissues transplantation. Actualities and perspectives” dedicated to the 10th anniversary of the founding of the Human Tissue and Cells Bank and to the 15th anniversary of the founding of the Laboratory of Tissue Engineering and Cells Culture of Nicolae Testemitanu State University of Medicine and Pharmacy of the Republic of Moldova, March 17-18th 2023, Chisinau, Republic of Moldovaen_US
dc.subjectplatelet rich growth factoren_US
dc.subjectcorneal disordersen_US
dc.subjectwound healingen_US
dc.titlePlatelet rich growth factor in the treatment of complex corneal disordersen_US
dc.typeOtheren_US
Appears in Collections:The Materials of the National Scientific Conference with International Participation „Cells and tissues transplantation. Actualities and perspectives”

Files in This Item:
File Description SizeFormat 
Platelet_rich_growth_factor_in_the_treatment_of_complex_corneal_disorders.pdf90.4 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback